Table 3.
Characteristics of AR patients and controls in stage II
| Parameters | AR patients (N = 48) | Controls (N = 50) | P Value |
|---|---|---|---|
| Age (years) | 23.25 ± 6.90 | 25.14 ± 8.38 | 0.266 |
| Female (n/%) | 24 (50.0) | 28 (56.0) | 0.552 |
| Disease Duration (months) | 79 (61-118) | - | - |
| INSS score | - | - | |
| Nasal rhinorrhea | 1.90 ± 0.10 | - | - |
| Itching | 1.85 ± 0.08 | - | - |
| Sneezing | 2.31 ± 0.10 | - | - |
| Congestion | 1.96 ± 0.10 | - | - |
| TNSS score | 8.02 ± 0.23 | - | - |
Data arepresented as mean value ± standard deviation, median (quartile 25th-75th) or count (%). Comparison weredetermined by t test or Chi-square test. P value < 0.05 was considered statistically significant. AR, allergic rhinitis; INSS, individual nasal symptom score; TNSS, total nasal symptom score.